CancerVax

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines
See more in Biomedtracker

Latest on CancerVax

Scrip

Deal Watch: A Closer Look At Boehringer Ingelheim’s Partnering Strategy

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim GmbH is closely

Scrip

Asia Deal Watch: EpimAb Licenses Bispecific Antibody To Newly Formed Vignette

 
• By Joseph Haas, Dexter Jie Yan, Xu Hu, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Vignette Gets Rights To BCMA×CD3 Bispec